Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart

Anna Picca, Giuseppe Sirago, Vito Pesce, Angela Maria Serena Lezza, Riccardo Calvani, Maurizio Bossola, Emanuele Rocco Villani, Francesco Landi, Christiaan Leeuwenburgh, Roberto Bernabei, Christy S. Carter, Emanuele Marzetti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Mitochondrial dysfunction is a relevant mechanism in cardiac aging. Here, we investigated the effects of late-life enalapril administration at a non-antihypertensive dose on mitochondrial genomic stability, oxidative damage, and mitochondrial quality control (MQC) signaling in the hearts of aged rats. The protein expression of selected mediators (i.e., mitochondrial antioxidant enzymes, energy metabolism, mitochondrial biogenesis, dynamics, and autophagy) was measured in old rats randomly assigned to receive enalapril (n = 8) or placebo (n = 8) from 24 to 27 months of age. We also assessed mitochondrial DNA (mtDNA) content, citrate synthase activity, oxidative lesions to protein and mtDNA (i.e., carbonyls and the abundance of mtDNA4834 deletion), and the mitochondrial transcription factor A (TFAM) binding to specific mtDNA regions. Enalapril attenuated cardiac hypertrophy and oxidative stress-derived damage (mtDNA oxidation, mtDNA4834 deletion, and protein carbonylation), while increasing mitochondrial antioxidant defenses. The binding of mitochondrial transcription factor A to mtDNA regions involved in replication and deletion generation was enhanced following enalapril administration. Increased mitochondrial mass as well as mitochondriogenesis and autophagy signaling were found in enalapril-treated rats. Late-life enalapril administration mitigates age-dependent cardiac hypertrophy and oxidative damage, while increasing mitochondrial mass and modulating MQC signaling. Further analyses are needed to conclusively establish whether enalapril may offer cardioprotection during aging.

Original languageEnglish
JournalBiomolecules
Volume8
Issue number4
DOIs
Publication statusPublished - Dec 17 2018

Fingerprint

Enalapril
Oxidative stress
Quality Control
Hypertrophy
Quality control
Rats
Oxidative Stress
Mitochondrial DNA
Autophagy
Cardiomegaly
Antioxidants
Aging of materials
Protein Carbonylation
Mitochondrial Dynamics
Carbonylation
Citrate (si)-Synthase
Genomic Instability
Organelle Biogenesis
Energy Metabolism
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart. / Picca, Anna; Sirago, Giuseppe; Pesce, Vito; Lezza, Angela Maria Serena; Calvani, Riccardo; Bossola, Maurizio; Villani, Emanuele Rocco; Landi, Francesco; Leeuwenburgh, Christiaan; Bernabei, Roberto; Carter, Christy S.; Marzetti, Emanuele.

In: Biomolecules, Vol. 8, No. 4, 17.12.2018.

Research output: Contribution to journalArticle

Picca, Anna ; Sirago, Giuseppe ; Pesce, Vito ; Lezza, Angela Maria Serena ; Calvani, Riccardo ; Bossola, Maurizio ; Villani, Emanuele Rocco ; Landi, Francesco ; Leeuwenburgh, Christiaan ; Bernabei, Roberto ; Carter, Christy S. ; Marzetti, Emanuele. / Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart. In: Biomolecules. 2018 ; Vol. 8, No. 4.
@article{9906c062513d4460a1a2b2c5ab594a3d,
title = "Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart",
abstract = "Mitochondrial dysfunction is a relevant mechanism in cardiac aging. Here, we investigated the effects of late-life enalapril administration at a non-antihypertensive dose on mitochondrial genomic stability, oxidative damage, and mitochondrial quality control (MQC) signaling in the hearts of aged rats. The protein expression of selected mediators (i.e., mitochondrial antioxidant enzymes, energy metabolism, mitochondrial biogenesis, dynamics, and autophagy) was measured in old rats randomly assigned to receive enalapril (n = 8) or placebo (n = 8) from 24 to 27 months of age. We also assessed mitochondrial DNA (mtDNA) content, citrate synthase activity, oxidative lesions to protein and mtDNA (i.e., carbonyls and the abundance of mtDNA4834 deletion), and the mitochondrial transcription factor A (TFAM) binding to specific mtDNA regions. Enalapril attenuated cardiac hypertrophy and oxidative stress-derived damage (mtDNA oxidation, mtDNA4834 deletion, and protein carbonylation), while increasing mitochondrial antioxidant defenses. The binding of mitochondrial transcription factor A to mtDNA regions involved in replication and deletion generation was enhanced following enalapril administration. Increased mitochondrial mass as well as mitochondriogenesis and autophagy signaling were found in enalapril-treated rats. Late-life enalapril administration mitigates age-dependent cardiac hypertrophy and oxidative damage, while increasing mitochondrial mass and modulating MQC signaling. Further analyses are needed to conclusively establish whether enalapril may offer cardioprotection during aging.",
author = "Anna Picca and Giuseppe Sirago and Vito Pesce and Lezza, {Angela Maria Serena} and Riccardo Calvani and Maurizio Bossola and Villani, {Emanuele Rocco} and Francesco Landi and Christiaan Leeuwenburgh and Roberto Bernabei and Carter, {Christy S.} and Emanuele Marzetti",
year = "2018",
month = "12",
day = "17",
doi = "10.3390/biom8040177",
language = "English",
volume = "8",
journal = "Biomolecules",
issn = "2218-273X",
publisher = "MDPI AG",
number = "4",

}

TY - JOUR

T1 - Administration of Enalapril Started Late in Life Attenuates Hypertrophy and Oxidative Stress Burden, Increases Mitochondrial Mass, and Modulates Mitochondrial Quality Control Signaling in the Rat Heart

AU - Picca, Anna

AU - Sirago, Giuseppe

AU - Pesce, Vito

AU - Lezza, Angela Maria Serena

AU - Calvani, Riccardo

AU - Bossola, Maurizio

AU - Villani, Emanuele Rocco

AU - Landi, Francesco

AU - Leeuwenburgh, Christiaan

AU - Bernabei, Roberto

AU - Carter, Christy S.

AU - Marzetti, Emanuele

PY - 2018/12/17

Y1 - 2018/12/17

N2 - Mitochondrial dysfunction is a relevant mechanism in cardiac aging. Here, we investigated the effects of late-life enalapril administration at a non-antihypertensive dose on mitochondrial genomic stability, oxidative damage, and mitochondrial quality control (MQC) signaling in the hearts of aged rats. The protein expression of selected mediators (i.e., mitochondrial antioxidant enzymes, energy metabolism, mitochondrial biogenesis, dynamics, and autophagy) was measured in old rats randomly assigned to receive enalapril (n = 8) or placebo (n = 8) from 24 to 27 months of age. We also assessed mitochondrial DNA (mtDNA) content, citrate synthase activity, oxidative lesions to protein and mtDNA (i.e., carbonyls and the abundance of mtDNA4834 deletion), and the mitochondrial transcription factor A (TFAM) binding to specific mtDNA regions. Enalapril attenuated cardiac hypertrophy and oxidative stress-derived damage (mtDNA oxidation, mtDNA4834 deletion, and protein carbonylation), while increasing mitochondrial antioxidant defenses. The binding of mitochondrial transcription factor A to mtDNA regions involved in replication and deletion generation was enhanced following enalapril administration. Increased mitochondrial mass as well as mitochondriogenesis and autophagy signaling were found in enalapril-treated rats. Late-life enalapril administration mitigates age-dependent cardiac hypertrophy and oxidative damage, while increasing mitochondrial mass and modulating MQC signaling. Further analyses are needed to conclusively establish whether enalapril may offer cardioprotection during aging.

AB - Mitochondrial dysfunction is a relevant mechanism in cardiac aging. Here, we investigated the effects of late-life enalapril administration at a non-antihypertensive dose on mitochondrial genomic stability, oxidative damage, and mitochondrial quality control (MQC) signaling in the hearts of aged rats. The protein expression of selected mediators (i.e., mitochondrial antioxidant enzymes, energy metabolism, mitochondrial biogenesis, dynamics, and autophagy) was measured in old rats randomly assigned to receive enalapril (n = 8) or placebo (n = 8) from 24 to 27 months of age. We also assessed mitochondrial DNA (mtDNA) content, citrate synthase activity, oxidative lesions to protein and mtDNA (i.e., carbonyls and the abundance of mtDNA4834 deletion), and the mitochondrial transcription factor A (TFAM) binding to specific mtDNA regions. Enalapril attenuated cardiac hypertrophy and oxidative stress-derived damage (mtDNA oxidation, mtDNA4834 deletion, and protein carbonylation), while increasing mitochondrial antioxidant defenses. The binding of mitochondrial transcription factor A to mtDNA regions involved in replication and deletion generation was enhanced following enalapril administration. Increased mitochondrial mass as well as mitochondriogenesis and autophagy signaling were found in enalapril-treated rats. Late-life enalapril administration mitigates age-dependent cardiac hypertrophy and oxidative damage, while increasing mitochondrial mass and modulating MQC signaling. Further analyses are needed to conclusively establish whether enalapril may offer cardioprotection during aging.

UR - http://www.scopus.com/inward/record.url?scp=85058883535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058883535&partnerID=8YFLogxK

U2 - 10.3390/biom8040177

DO - 10.3390/biom8040177

M3 - Article

C2 - 30563025

AN - SCOPUS:85058883535

VL - 8

JO - Biomolecules

JF - Biomolecules

SN - 2218-273X

IS - 4

ER -